Universal Vision Biotechnology Co., Ltd. announced the change of the principal financial and accounting officer of the Company. Name, title, and resume of the previous position holder: Principle financial and accounting officer: Sophia Lien (Substitute); Name, title, and resume of the new position holder: Principle financial and accounting officer: Cindy Sun, vice president of financial department of Grand Pacific Investment & Development Co., Ltd.; senior financial manager of Chailease Finance; and assurance services manager of PricewaterhouseCoopers Taiwan; Reason for the change: Position adjustment; Effective date is October 20, 2022.
Universal Vision Biotechnology Co., Ltd.
Equities
3218
TW0003218004
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
253 TWD | -1.36% | -1.17% | -8.66% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.66% | 662M | |
+11.12% | 39.61B | |
-2.77% | 18.28B | |
-14.88% | 2.39B | |
-11.77% | 1.48B | |
+24.21% | 1.19B | |
-34.38% | 763M | |
-35.25% | 744M | |
+26.26% | 506M | |
+26.91% | 477M |
- Stock Market
- Equities
- 3218 Stock
- News Universal Vision Biotechnology Co., Ltd.
- Universal Vision Biotechnology Co., Ltd. Announces Principal Financial and Accounting Officer Changes